Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease

Chris Schilling (), Duncan Mortimer, Kim Dalziel, Emma Heeley, John Chalmers and Philip Clarke

PharmacoEconomics, 2016, vol. 34, issue 2, 195-205

Abstract: There is little evidence that AR guidelines recommended by the National Heart Foundation and National Vascular Disease Prevention Alliance, or conditional individual risk eligibility guidelines from the Pharmaceutical Benefits Scheme, are adopted in prescribing practice. The hierarchy of conditional relationships between risk factors and socioeconomic factors identified by CART provides new insights into prescribing decisions. Overall, CART is a useful addition to the analyst’s toolkit when investigating healthcare decisions. Copyright Springer International Publishing Switzerland 2016

Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
http://hdl.handle.net/10.1007/s40273-015-0342-3 (text/html)
Access to full text is restricted to subscribers.

Related works:
Journal Article: Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease (2016)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:34:y:2016:i:2:p:195-205

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-015-0342-3

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().